Haemonetics Corporation
NYSEHaemonetics delivered a clean earnings beat on August 6 and the Street responded fast — target prices moved sharply higher across the board, with the stock now sitting at $87.84 and up 17% over the past month. The analyst reaction tells the clearest story this week. Multiple firms raised targets within 24 hours of the print. JP Morgan's Allen Gong lifted his target from $62 to $86…
HAE short interest surges 31% in one week to 5.66% of float, driven by recent analyst upgrades and Q3 beat.
Snapshot as of 18 Aug 2026
Haemonetics delivered a clean earnings beat on August 6 and the Street responded fast — target prices moved sharply higher across the board, with the stock now sitting at $87.84 and up 17% over the past month. The…
HAE heads into its August 6 earnings report with the options market sending a clear bullish signal — one that the stock's sharp recent rally has done nothing to contradict. The most striking positioning data is in…
Haemonetics heads into the summer with a split personality: the analyst community is upgrading its view just as short sellers add to their bets — a tension the stock's recent price action has not yet resolved. The…
Haemonetics Corporation enters its May 7 earnings call in an unusual spot: short sellers have been cutting exposure for six weeks, options traders are positioned bullishly, and yet the stock trades at a near-50%…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HAE — free to start on ORTEX.
Sign up for free →Open HAE on ORTEX